Renqiang Yu | Medicine and Dentistry | Best Researcher Award

Dr. Renqiang Yu | Medicine and Dentistry | Best Researcher Award

Deputy Chief PhysicianΒ  at Affiliated Women’s Hospital of Jiangnan University, China

Dr. Renqiang Yu, born on November 3, 1986, is a distinguished Chinese medical professional specializing in pediatrics and clinical research. He currently serves as a Deputy Chief Physician at the Affiliated Women’s Hospital of Jiangnan University. With a robust academic background, Dr. Yu has contributed significantly to the fields of pulmonary angiogenesis, atopic dermatitis, and neonatal health. His recent research focuses on the role of probiotics and short-chain fatty acids in health and disease prevention. He leads multiple nationally funded projects and has published extensively in high-impact journals, covering topics such as gut health, microbiota, and immune modulation. Dr. Yu’s leadership is recognized through his editorial role at Frontiers in Microbiology as a guest associate editor. His innovative research continues to enhance neonatal care and improve the quality of life for children affected by various conditions, positioning him as a leader in his field.

Professional Profile

Education

Dr. Renqiang Yu earned his Doctor of Medicine (M.D.) degree from Nanjing Medical University, one of China’s top medical institutions. His educational journey provided him with a strong foundation in medical sciences, particularly in pediatrics and clinical research. His academic training was marked by a focus on pediatric diseases, neonatology, and immunology, equipping him with the expertise to address critical issues in neonatal health. Dr. Yu’s commitment to advancing medical research is reflected in his continuous engagement with the latest scientific advancements, as he integrates cutting-edge knowledge into his clinical practice. This rigorous academic background has played a crucial role in his ability to lead groundbreaking research and medical initiatives that address public health challenges.

Professional Experience

Dr. Renqiang Yu has a notable career in both clinical and research settings. Currently, he is the Deputy Chief Physician at the Affiliated Women’s Hospital of Jiangnan University, where he leads clinical practices focusing on pediatric and neonatal care. In addition to his clinical duties, Dr. Yu plays an instrumental role in shaping medical research, particularly through his leadership in multiple funded projects. He has served as the principal investigator for projects funded by the National Natural Science Foundation of China, exploring topics such as pulmonary angiogenesis and atopic dermatitis. His work has earned recognition from both national and international scientific communities. Dr. Yu’s diverse professional roles, including his editorial position with Frontiers in Microbiology, reflect his broad impact in the medical field, bridging clinical excellence with groundbreaking research initiatives.

Research Interest

Dr. Renqiang Yu’s research interests focus primarily on pediatrics, neonatal health, and clinical immunology, with a special emphasis on gut microbiota and its impact on immune function. His work explores the mechanisms of pulmonary angiogenesis, particularly in neonates, and the role of probiotics and short-chain fatty acids in disease prevention and immune regulation. Dr. Yu has also delved into the pathophysiology of atopic dermatitis, investigating novel therapeutic approaches to treat this condition. His research contributes significantly to understanding the gut-skin axis and its implications for pediatric diseases. Furthermore, he is interested in the development of innovative treatments for neonatal illnesses, striving to improve patient outcomes through the application of his findings. Through these endeavors, Dr. Yu seeks to bridge the gap between basic science and clinical applications, paving the way for improved pediatric healthcare practices worldwide.

Awards and Honors

Dr. Renqiang Yu has received numerous prestigious awards and honors throughout his career, reflecting his outstanding contributions to the fields of pediatrics and medical research. He was recognized as a key participant in national research initiatives, securing multiple grants from the National Natural Science Foundation of China for his studies on pediatric diseases and immune system modulation. Dr. Yu’s innovative work has earned him recognition from leading academic institutions, and his contributions to advancing neonatal care have been widely acknowledged by his peers. His editorial role in Frontiers in Microbiology further underscores his leadership in the academic community. In addition to these honors, Dr. Yu has been invited to deliver lectures at various international conferences, where he shares his expertise on pediatric immunology and gut health. These accolades affirm his standing as a leading researcher in the field, dedicated to advancing healthcare for children globally.

Publications Top Noted

  • Title: Nrf2 protects against seawater drowning-induced acute lung injury via inhibiting ferroptosis
    Authors: Y Qiu, B Wan, G Liu, Y Wu, D Chen, M Lu, J Chen, R Yu, D Chen, Q Pang
    Journal: Respiratory Research
    Year: 2020
    Citations: 131
  • Title: Inhibition of HMGB1 improves necrotizing enterocolitis by inhibiting NLRP3 via TLR4 and NF‐κB signaling pathways
    Authors: R Yu, S Jiang, Y Tao, P Li, J Yin, Q Zhou
    Journal: Journal of Cellular Physiology
    Year: 2019
    Citations: 109
  • Title: Fatty acid profile and the sn-2 position distribution in triacylglycerols of breast milk during different lactation stages
    Authors: C Qi, J Sun, Y Xia, R Yu, W Wei, J Xiang, Q Jin, H Xiao, X Wang
    Journal: Journal of Agricultural and Food Chemistry
    Year: 2018
    Citations: 102
  • Title: Maternal vitamin D status in the late second trimester and the risk of severe preeclampsia in Southeastern China
    Authors: X Zhao, R Fang, R Yu, D Chen, J Zhao, J Xiao
    Journal: Nutrients
    Year: 2017
    Citations: 99
  • Title: Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice
    Authors: CL Campbell, R Yu, F Li, Q Zhou, D Chen, C Qi, Y Yin, J Sun
    Journal: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
    Year: 2019
    Citations: 79
  • Title: Triacylglycerol composition of breast milk during different lactation stages
    Authors: T Yuan, C Qi, X Dai, Y Xia, C Sun, J Sun, R Yu, Q Zhou, Q Jin, W Wei, …
    Journal: Journal of Agricultural and Food Chemistry
    Year: 2019
    Citations: 68
  • Title: Lactobacillus reuteri improves gut barrier function and affects diurnal variation of the gut microbiota in mice fed a high-fat diet
    Authors: S Li, C Qi, H Zhu, R Yu, C Xie, Y Peng, SW Yin, J Fan, S Zhao, J Sun
    Journal: Food & Function
    Year: 2019
    Citations: 58
  • Title: Evaluating the activity of sodium butyrate to prevent osteoporosis in rats by promoting osteal GSK-3Ξ²/Nrf2 signaling and mitochondrial function
    Authors: X Tang, S Ma, Y Li, Y Sun, K Zhang, Q Zhou, R Yu
    Journal: Journal of Agricultural and Food Chemistry
    Year: 2020
    Citations: 46
  • Title: Short-chain fatty acid (SCFA) and medium-chain fatty acid (MCFA) concentrations in human milk consumed by infants born at different gestational ages and the variations in …
    Authors: X Dai, T Yuan, X Zhang, Q Zhou, H Bi, R Yu, W Wei, X Wang
    Journal: Food & Function
    Year: 2020
    Citations: 44
  • Title: Protective effects of Ξ³-aminobutyric acid against H2O2-induced oxidative stress in RIN-m5F pancreatic cells
    Authors: X Tang, R Yu, Q Zhou, S Jiang, G Le
    Journal: Nutrition & Metabolism
    Year: 2018
    Citations: 40

Weifang Liao | Medicine and Dentistry | Best Researcher Award

Dr. Weifang Liao | Medicine and Dentistry | Best Researcher Award

Associate Professor at Jiujiang University Affiliated Hospital, China

Weifang Liao is an Associate Professor at the School of Clinical Medicine, Jiujiang University. With a strong background in medicine and epidemiology, Liao has actively contributed to biomedical research, particularly in wound healing and drug delivery systems. His work integrates traditional Chinese and Western medicine, emphasizing innovative approaches in biomaterials and hydrogel-based therapeutics. He has secured multiple research grants and published extensively in high-impact journals. Liao’s research has been instrumental in advancing regenerative medicine and improving treatment methodologies for complex medical conditions, including diabetic wound healing and colorectal cancer diagnostics.

Professional ProfileΒ 

Education

Weifang Liao earned his Ph.D. in Medicine from Wonkwang University, South Korea, in 2021. He holds a Master’s degree in Epidemiology and Health Statistics from Guizhou Medical University, obtained in 2015. His academic journey began at Jiujiang University, where he studied Integrated Chinese and Western Medicine from 2003 to 2006. His educational background reflects a strong foundation in medical research, public health, and clinical applications, equipping him with interdisciplinary expertise to contribute significantly to the field of biomedical science and healthcare innovation.

Professional Experience

Liao is currently an Associate Professor at Jiujiang University’s School of Clinical Medicine. Previously, he was a Lecturer at the same institution from 2015 to 2018. He also gained practical medical experience as a Medical Officer at Zhegang Health Center under the Poyang County Health Commission (2008-2012). His postdoctoral research at Wonkwang University (2021-2022) enhanced his expertise in biomaterials and medical technology. Additionally, he has been engaged in academic collaborations with Huazhong University of Science and Technology, furthering his contributions to medical education and research.

Research Interests

Liao’s research focuses on biomaterials, regenerative medicine, and targeted drug delivery. He is particularly interested in 3D-bioprinted hydrogels for wound healing and the application of magnetic hydrogel microspheres in advanced drug delivery. His work also explores the diagnostic and prognostic markers for colorectal cancer and novel therapeutic strategies for inflammatory bowel diseases. His projects, funded by prestigious institutions, integrate microfluidic technology, exosome-loaded curcumin chitosan, and smart hydrogels to address medical challenges in tissue regeneration and cancer treatment.

Awards and Honors

Liao has been a key participant and principal investigator in several high-impact research projects funded by the National Natural Science Foundation of China, the National Research Foundation of Korea, and various provincial agencies. His research has resulted in multiple first-author and corresponding-author publications in leading journals like International Journal of Biological Macromolecules and Materials Today Bio. While he has not received formal academic awards, his contributions to biomaterial research and regenerative medicine have gained significant recognition in the scientific community.

Publications Top Noted

  • Title: Advances in 3D printing combined with tissue engineering for nerve regeneration and repair
    Authors: Liao, W., Shi, Y., Li, Z., Yin, X.
    Year: 2025
    Citation Count: 0
  • Title: Advanced biomaterials for diabetes healthcare and complication therapy: A review
    Authors: Wang, G., Liao, W., Han, F., Shi, Y., Hu, Z.
    Year: 2024
    Citation Count: 0
  • Title: Advances of biological macromolecules hemostatic materials: A review
    Authors: Zhang, M., Han, F., Duan, X., Cui, Q., Liao, W.
    Year: 2024
    Citation Count: 2
  • Title: Natural polyphenols for drug delivery and tissue engineering construction: A review
    Authors: Liu, Y., Shi, Y., Zhang, M., Liao, W., Duan, X.
    Year: 2024
    Citation Count: 14
  • Title: Biomaterials for inflammatory bowel disease: treatment, diagnosis and organoids
    Authors: Wang, J., Shi, Y., Mao, B., Hu, Z., Liao, W.
    Year: 2024
    Citation Count: 5
  • Title: Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications
    Authors: Ding, J., Ding, X., Liao, W., Lu, Z.
    Year: 2024
    Citation Count: 5
  • Title: Revolutionizing digestive system tumor organoids research: Exploring the potential of tumor organoids
    Authors: Xiu, Z., Yang, Q., Xie, F., He, W., Liao, W.
    Year: 2024
    Citation Count: 1
  • Title: 3D-bioprinted double-crosslinked angiogenic alginate/chondroitin sulfate patch for diabetic wound healing
    Authors: Liao, W., Duan, X., Xie, F., Wang, X., Hu, Z.
    Year: 2023
    Citation Count: 21
  • Title: The Association Between Serum Endocan Level and Short-Term Prognosis of Patients With Acute Ischemic Stroke
    Authors: Han, F., Liao, W., Duan, X., Shi, Y., Hu, Z.
    Year: 2022
    Citation Count: 6
  • Title: 3D-bioprinted peptide coupling patches for wound healing
    Authors: Guan, G., Lv, Q., Liu, S., Zhou, C., Liao, W.
    Year: 2022
    Citation Count: 53

Daniel Lee | Medicine and Dentistry | Best Researcher Award

Dr. Daniel Lee | Medicine and Dentistry | Best Researcher Award

Senior Consultant at Khoo Teck Puat Hospital, Singapore

Dr. Daniel Lee Jin Keat is a highly accomplished Malaysian surgeon with extensive qualifications, including an MD from University Putra Malaysia and multiple postgraduate certifications, such as FRCS and FAMS. Currently a senior consultant at Khoo Teck Puat Hospital in Singapore, he has significant experience in colorectal and trauma surgery, complemented by international fellowships at prestigious institutions in the UK. Dr. Lee has authored numerous publications in reputable medical journals, focusing on critical areas such as trauma care, surgical techniques, and postoperative recovery strategies. His research contributions demonstrate a commitment to advancing surgical practices and improving patient outcomes. Additionally, he is recognized for his expertise through specialist accreditation. With a blend of clinical practice and academic research, Dr. Lee is poised to continue making meaningful contributions to the field of surgery, exemplifying dedication to both patient care and medical innovation.

Professional Profile

Education

Dr. Daniel Lee Jin Keat’s educational background is marked by rigorous training and prestigious qualifications. He began his academic journey at Chi Hwa Primary School and Chan Wa Secondary School in Malaysia before advancing to pre-university studies at SMK Tunku Ampuan Durah. He earned his Doctor of Medicine (MD) from University Putra Malaysia, completing his undergraduate degree from 1999 to 2004. Following this, Dr. Lee pursued further specialization, obtaining the Membership of the Royal College of Surgeons (MRCS) in Edinburgh in 2009. He continued his postgraduate education, earning a Master of Medicine (MMed) in Singapore in 2015. His commitment to excellence in surgery culminated in obtaining the Fellowship of the Royal College of Surgeons (FRCS) in 2015 and becoming a Fellow of the Academy of Medicine, Singapore (FAMS). This extensive educational foundation has equipped him with the skills and knowledge essential for his successful career in surgery.

Professional Experience

Dr. Daniel Lee Jin Keat is a distinguished senior consultant surgeon specializing in colorectal and trauma surgery at Khoo Teck Puat Hospital in Singapore. His professional journey began with the completion of his MRCS in 2009, followed by a series of key roles in general surgery at various reputable institutions, including Alexandra Hospital and Khoo Teck Puat Hospital. Dr. Lee underwent advanced specialist training, achieving his FRCS in 2015. He further enhanced his expertise through international fellowships at St James’s University Hospital and the Royal London Hospital, focusing on colorectal and trauma surgery, respectively. Dr. Lee has made significant contributions to the medical community through numerous publications in esteemed journals, covering critical topics in surgical practice and patient care. His dedication to improving surgical outcomes and trauma care has established him as a respected figure in his field, reflecting his commitment to excellence in both clinical and academic pursuits.

Research Interests

Dr. Daniel Lee Jin Keat’s research interests are primarily focused on advancing surgical practices in colorectal and trauma surgery. His work emphasizes critical areas such as surgical techniques, postoperative recovery, and the management of complications in surgical procedures. Dr. Lee has conducted significant research on topics including laparoscopic surgeries, the impact of frailty on surgical outcomes, and strategies to reduce surgical site infections. He is particularly interested in the application of enhanced recovery after surgery (ERAS) protocols, exploring how prehabilitation and optimized surgical practices can improve patient recovery times and overall outcomes. His publications reflect a commitment to evidence-based medicine, often analyzing trends in surgical interventions and their effectiveness. Through his research, Dr. Lee aims to contribute to the development of innovative approaches in surgical care, ultimately enhancing the quality of treatment for patients undergoing complex surgical procedures.

Awards and Honors

Dr. Daniel Lee Jin Keat has received several prestigious awards and honors throughout his medical career, reflecting his dedication and contributions to the field of surgery. Notably, he has earned the Fellowship of the Royal College of Surgeons (FRCS) and the Fellowship of the Academy of Medicine, Singapore (FAMS), both of which signify his exceptional skills and commitment to surgical excellence. His work has been recognized through various accolades for his impactful research, particularly in the domains of colorectal and trauma surgery. Dr. Lee’s publications have garnered attention in esteemed medical journals, underscoring his role as a thought leader in surgical practice. Additionally, he has been acknowledged for his involvement in international fellowships, which have further enriched his expertise and knowledge. These awards and honors not only highlight Dr. Lee’s professional achievements but also reflect his ongoing commitment to improving patient care and advancing surgical methodologies.

Conclusion

Dr. Daniel Lee Jin Keat exhibits numerous qualities that make him a strong candidate for the Best Researcher Award. His extensive educational background, diverse professional experiences, significant contributions to surgical research, and commitment to improving clinical practices underscore his suitability. However, by addressing areas for improvementβ€”such as increasing community engagement and expanding the diversity of his research focusβ€”he could further enhance his profile as a leading researcher. Overall, he has the potential to make substantial contributions to the medical field, and the recognition from this award would be a fitting acknowledgment of his achievements.

Publication top noted

  • Koh, F.H., Chew, L.M.Y., Wong, N., How, K.-Y., Ng, D.H.
    Title: Perioperative management of sarcopenia in patients undergoing major surgeries in Singapore: a modified Delphi consensus
    Journal: International Journal of Surgery (London, England)
    Year: 2024
    Citation: 110(8), pp. 4552–4558.
  • Chan, K.S., Lee, D.J.K., Kok, Y.D., Heng, G.K.E., Tan, K.Y.
    Title: A 10-year review on older patients undergoing colorectal cancer surgery: surgeon-led geriatric service and good quality surgery are drivers of good outcomes
    Journal: Journal of Gastrointestinal Surgery
    Year: 2024
    Citation: 28(1), pp. 40–46.
  • Lau, J., Khoo, A.M.-G., Peh, C.H., Luo, N., Tan, K.-K.
    Title: Health-related quality of life thresholds of clinical importance at diagnosis can predict longitudinal post-operative health functioning in colorectal cancer patients: A prospective multicentre observational study
    Journal: European Journal of Surgical Oncology
    Year: 2024
    Citation: 50(1), 107291.
  • Kang, M.L., Lim, W.W., Lee, D.J.K., Goo, J.T.T.
    Title: Impact of nationwide COVID-19 lockdown on workload and injury patterns of major trauma cases in a regional trauma centre in Singapore
    Journal: Singapore Medical Journal
    Year: 2023
    Citation: 64(11), pp. 677–682.
  • Lei, G., Tan, L., Mantoo, S.K., Lee, D.
    Title: Reducing Surgical Site Infection in Colorectal Surgery Using Mechanical Bowel Preparation and Oral Antibiotics: a Comparative Study in the Era of Enhanced Recovery After Surgery (ERAS) Protocol
    Journal: Indian Journal of Surgery
    Year: 2023
    Citation: 85(4), pp. 919–924.
  • Tang, W.S.W., Wong, J.Q.H., Chan, S.W.K., Tan, K.Y., Lee, D.J.K.
    Title: Re: The changing landscape of general surgery in the elderly – trends over a decade in a tertiary centre in Singapore
    Journal: ANZ Journal of Surgery
    Year: 2023
    Citation: 93(3), pp. 782–783.
  • Tan, E.W.K., Yeo, J.Y., Lee, Y.Z., Lim, W.W., Lee, D.J.K.
    Title: Low skeletal muscle mass predicts poor prognosis of elderly patients after emergency laparotomy: A single Asian institution experience
    Journal: Annals of the Academy of Medicine, Singapore
    Year: 2022
    Citation: 51(12), pp. 766–773.
  • Kang, M.L., Goo, J.T.T., Lee, D.J.K.
    Title: CHOP protocol: Streamlining access to definitive intervention for major trauma victims
    Journal: Singapore Medical Journal
    Year: 2021
    Citation: 62(12), pp. 620–622.
  • Tang, M.H., Wong, J.S.H., Chia, C.L.K., Lee, D.J.K.
    Title: Meta-analysis on surgical management of colonic injuries in trauma: to divert or to anastomose?
    Journal: European Journal of Trauma and Emergency Surgery
    Year: 2021
    Citation: 47(5), pp. 1381–1388.
  • Lee, D.J.K., Kang, M.L., Christie, L.M.J., Patel, S., Goo, J.T.T.
    Title: Improving trauma care in exsanguinating patients with CHOP (critical haemorrhage to operating-room patient) resuscitation protocolβ€”A cumulative summation (CUSUM) analysis
    Journal: Injury
    Year: 2021
    Citation: 52(9), pp. 2508–2514.

Mohamed Ali | Medicine and Dentistry | Best Researcher Award

Dr. Mohamed Ali | Medicine and Dentistry | Best Researcher Award

Alexandria faculty of medicine at Faculty of medicine alexandria university, Egypt

Dr. Sheryene Tejeda is an accomplished medical researcher and consultant with over 15 years of experience in clinical and scientific settings. Based in Palm Beach Gardens, Florida, she has led and contributed to significant advancements in integrative therapies, medical research, and protocol development. Her work spans across fields such as oncology, neurology, and behavioral health, where she has held prominent positions including Lead Medical Scientist at Medicinal Technologies and Clinical Research Associate. Dr. Tejeda’s multidisciplinary background has equipped her to excel in both academic and applied sciences, making her a key figure in the biomedical community.

Professional Profile

Education

Dr. Tejeda holds a PhD in Biomedical Science from Einstein Medical School, where she honed her expertise in medical research methodologies and translational medicine. Her academic journey also includes a Master’s in Forensic Science and a Master’s in Health Science, providing her with a robust foundation in health diagnostics, legal medicine, and therapeutic innovation. Additionally, she holds a Bachelor’s degree in Communications and Psychology, reflecting her versatile knowledge base and holistic understanding of human behavior and communication in healthcare contexts.

Professional Experience

Throughout her career, Dr. Tejeda has held pivotal roles in both research and clinical environments. She has served as Lead Medical Scientist at Medicinal Technologies, where she spearheaded groundbreaking research and therapeutic protocols. In her role as a Clinical Research Associate, she collaborated on innovative clinical trials and co-occurring disorder treatment protocols. She also worked as a Contract Co-occurring Consultant, providing expert insights into behavioral health interventions. Her experience is marked by her ability to bridge scientific theory and clinical application, contributing to the development of integrative therapies and patient-centric treatments.

Research Interests

Dr. Tejeda’s research interests are deeply rooted in medical innovation, particularly in integrative therapies that combine conventional and alternative treatments. She is passionate about advancing personalized medicine approaches in oncology and neurology, focusing on the molecular mechanisms of disease and novel therapeutic strategies. Her work also extends to behavioral health, exploring the intersection of mental health and chronic diseases. Dr. Tejeda is dedicated to translating research findings into practical clinical applications that improve patient outcomes and overall healthcare efficiency.

Awards and Honors

Dr. Tejeda has been recognized for her contributions to the medical field with several prestigious awards and honors. Her work in integrative therapy development has earned her accolades from both scientific and clinical communities. She has been acknowledged for her leadership in clinical trials and for pioneering patient-focused research initiatives. These honors reflect her commitment to advancing medical research and her impact on improving healthcare outcomes, particularly in oncology, neurology, and behavioral health. Her recognition highlights the innovative nature of her work and her influence as a leader in the biomedical field.

Conclusion

The candidate has a strong foundation of clinical expertise, leadership, and research experience, which makes them a compelling contender for the Best Researcher Award. However, to further strengthen their candidacy, they could focus on expanding their research output, engaging in more collaborative projects, and taking on larger research initiatives. These steps would position them even more favorably for recognition in the global research community.

Publication top noted

πŸ“ Authors: Mohamed Ali, Mohamed El-shafie, Mohamed El-sheikh, Ahmed Waly
πŸ“… Year: 2024
πŸ“š Publication Title: Prospective Comparative Study Between Peroneus Longus Tendon Autograft and Hamstring Tendons Autograft in Single Bundle ACL Reconstruction
πŸ“° Journal Title: Alexandria Journal of Medicine
πŸ“† Date of Publication: 07/10/2024